Tanshinone IIA Sodium Sulfonate Injection is available for intramuscular injection, intravenous injection, and intravenous drip, with a common dose of 40~80mg/dose. Tanshinone IIA Sodium Sulfonate Injection has three common uses: intramuscular injection, intravenous injection and intravenous drip. Intramuscular injection is 40~80mg/dose, once a day; intravenous injection is 40~80mg/dose, diluted with 20ml of 25% dextrose injection; intravenous drip is 40~80mg, diluted with 250~300ml of 5% dextrose injection or 0.9% sodium chloride injection, once a day. Tanshinone IIA Sodium Sulfonate is mainly used to assist in the treatment of coronary heart disease, angina pectoris, myocardial infarction, adverse reactions include abdominal pain, nausea, phlebitis, pain, hypotensive shock, fever, chills, anaphylactic shock, dermatitis, maculopapular rash, rashes and so on, and is contraindicated in patients who are allergic to this product. It is recommended that patients who are unwell go to a regular hospital in time, and follow the doctor’s instructions for symptomatic treatment with medication.